TUCSON
520.748.4400
About Us
Professional Staff
Board of Directors
Careers
Contact Us
Frederick Gardner
Cottrell Foundation
Successes
Ventures
Biotechnology
Medical Devices
Other
Historic Investments
Technologies
The CH2 Domain Scaffold – ABDURINS™
Deimmunized Sarcin Ribotoxin
Endotoxin-free ClearColi™ Expression System
Fibronectin Artificial Antibody Scaffold
Granulocyte-Macrophage Colony Stimulating Factor (GM-CSF)
Pichia Classic Expression Platform
Pichia GlyoSwitch™ Protein Expression System
Ultrasound Tissue Harmonic Imaging
VIMPAT® (lacosamide) for Treatment of Epileptic Seizures
Innovate With Us
News & Events
Home
»
News & Events
»
2023
Pheon Therapeutics Appoints Cyrus Mozayeni, MD as CEO
7.25.2023
Introducing Motive: FDA-Cleared Knee Pain Relief Therapy
7.10.2023
Pheon Therapeutics enters into license agreement with Biocytogen Pharmaceuticals
7.5.2023
C-Path’s TRxA Accelerates its First Drug Development Projects with Support from RCT’s Cottrell Foundation
6.28.2023
BioTools Innovator Announces 2023 Cohort
6.6.2023
Oligo Factory Opens New State-of-the-Art Oligo Manufacturing Facility with Funding from BroadOak and RCT
3.2.2023
Biolog Expands Series A Financing, Acquires MIDI Labs
1.4.2023
Prince Of Spray Drying Returns As Earl Of Dispersion At AustinPx
1.3.2023
News by Year
2026
2025
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
From concept
to market
Innovate with us ›